Fintel reports that on February 11, 2025, BMO Capital downgraded their outlook for Q32 Bio (LSE:0T6G) from Outperform to Market Perform.
What is the Fund Sentiment?
There are 173 funds or institutions reporting positions in Q32 Bio. This is an increase of 73 owner(s) or 73.00% in the last quarter. Average portfolio weight of all funds dedicated to 0T6G is 0.10%, an increase of 32.63%. Total shares owned by institutions increased in the last three months by 29.85% to 10,431K shares.
What are Other Shareholders Doing?
Orbimed Advisors holds 2,253K shares representing 18.50% ownership of the company. No change in the last quarter.
Atlas Venture Life Science Advisors holds 2,092K shares representing 17.18% ownership of the company. No change in the last quarter.
Carlyle Group holds 1,103K shares representing 9.05% ownership of the company. No change in the last quarter.
Monaco Asset Management SAM holds 575K shares representing 4.72% ownership of the company.
Adage Capital Partners Gp, L.l.c. holds 404K shares representing 3.32% ownership of the company.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
